Orange Biomed to Present a Revolutionary New Method of A1c Testing at ADA 2024 – Preview Before Public Release
Learn How The Microfluidic Technology In OBM rapid A1c, A New At-Home Device For Monitoring HbA1C, Can Generate Lab-Accurate Results From A Single Drop of Blood For More Accessible And Affordable Testing. Seattle, WA, June 4, 2024 —Orange Biomed—a South Korean diabetes management innovator—just announced today that they will present OBM rapid A1c, a reusable, […]